ArticleMedicine2026
Association of the composite dietary antioxidant index with advanced cardiovascular-kidney-metabolic syndrome in U.S. adults: A cross-sectional study based on NHANES 2001-2018.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to examine the association between the composite dietary antioxidant index (CDAI) and advanced cardiovascular-kidney-metabolic syndrome (CKM) and characterize its dose-response shape. This cross-sectional study included 23,968 National Health and Nutrition Examination Survey participants aged ≥20 years (2001-2018). Advanced CKM was stages 3 and 4 combined, per the 2023 American Heart Association framework. The CDAI was the sum of sex-specific z-scores for 6 dietary antioxidants (vitamins A, C, and E, carotenoids, zinc, and selenium) from a single 24-hour recall, analyzed in quartiles (Q1-Q4). Multivariable logistic regression assessed the association, and restricted cubic splines tested nonlinearity. Multiple imputation, propensity score matching, survey-weighted models, and subgroup analyses evaluated robustness. Crude prevalence of advanced CKM fell from 33.6% (Q1) to 20.8% (Q4). After full adjustment, odds ratios (ORs) vs Q1 were 0.87 (95% confidence interval 0.78-0.97) for Q2, 0.79 (0.70-0.89) for Q3, and 0.83 (0.72-0.95) for Q4 (P for trend = .002). Splines showed an L-shaped association with a nadir at a CDAI of approximately 0.36; below this threshold each 1-unit increase was associated with marginally lower odds (OR 0.96, 95% confidence interval 0.92-1.00, P = .048), whereas above it the association plateaued. The associations were consistent across age, sex, smoking, alcohol intake, poverty income ratio, and physical activity strata (all P for interaction > .05). After multiple imputation the Q4 OR was 0.77 (0.69-0.85); propensity score-matched and survey-weighted estimates were directionally consistent, with a significant trend in each (P for trend = .045, .039). A higher food-derived CDAI was independently associated with a lower prevalence of advanced CKM, with the inverse association confined to the low-to-moderate intake range. These findings are consistent with dietary guidance emphasizing whole foods rich in diverse antioxidants, although the cross-sectional design precludes causal inference.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.